Stratrix
On the Record · Henry Schein

Henry Schein acquisitions, on the record

The businesses Henry Schein bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Shield Healthcare, Inc.
Word for word“On October 2, 2023 we acquired a 90 % voting equity interest in Shield Healthcare, Inc. (“Shield”), a supplier of homecare medical products delivered directly to patients in their homes.” 10-K for 2023
acquisitionOn October 2, 2023—
S.I.N. Implant System
Word for word“On July 5, 2023, we acquired a 100 % voting equity interest in S.I.N. Implant System (“S.I.N.”).” 10-K for 2023
acquisitionOn July 5, 2023—
Midway Dental Supply
Word for word“On August 26, 2022, we acquired Midway Dental Supply.” 10-K for 2023
acquisitionOn August 26, 2022—
TriMed Inc.
Word for word“As described in Note 5 of the consolidated financial statements, the Company acquired TriMed Inc. (“TriMed”) in 2024.” 10-K for 2024
acquisitionin 2024—
Biotech Dental and S.I.N. Implant System
Word for word“The increase in local currency Global Specialty Products sales was attributable to the acquisitions of TriMed during the year ended December 28, 2024, and Biotech Dental and S.I.N. Implant System during the year ended December 30, 2023.” 10-K for 2024
acquisitionduring the year ended December 30, 2023—
BioHorizons
Word for word“Mr. Boggan joined Henry Schein, as the President and CEO of BioHorizons, which we acquired in 2014.” 10-K for 2024
acquisitionin 2014—
entities within the Global Distribution and Value-Added Services, Global Specialty Products and Global Technology segments
Word for word“As described in Notes 1 and 5 of the consolidated financial statements, the Company acquired entities within the Table of Contents Index to Financial Statements 71 Global Distribution and Value-Added Services, Global Specialty Products and Global Technology segments during the year ended December 27, 2025 for total consideration of $392 million.” 10-K for 2025
acquisitionduring the year ended December 27, 2025$392 million
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedGoodwill from acquisitions
2016-12-31$145.8 million
2017-12-30$224.9 million
2018-12-29$568.9 million
2019-12-28$388.6 million
2020-12-26$26.3 million
2021-12-25$383 million
2022-12-31$85 million
2023-12-30$945 million
2024-12-28$148 million
2025-12-27$199 million

Deal filings since 2016

Read from Henry Schein’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.